1995
DOI: 10.1172/jci118272
|View full text |Cite
|
Sign up to set email alerts
|

The aldehyde dehydrogenase ALDH2*2 allele exhibits dominance over ALDH2*1 in transduced HeLa cells.

Abstract: Individuals heterozygous or homozygous for the variant aldehyde dehydrogenase (ALDH2) allele (ALDH2 *2), which encodes a protein differing only at residue 487 from the normal protein, have decreased ALDH2 activity in liver extracts and experience cutaneous flushing when they drink alcohol. The mechanism by which this allele exerts its dominant effect is unknown. To study this effect, the human ALDH2 *1 cDNA was cloned and the ALDH2 *2 allele was generated by site-directed mutagenesis. These cDNAs were transduc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

13
74
1

Year Published

1999
1999
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 73 publications
(88 citation statements)
references
References 21 publications
13
74
1
Order By: Relevance
“…In all forms of the enzymes assayed, the ratio of 1,2-GDN/1,3-GDN was constant at 8:1. Furthermore, the decreased GTN biotransformation in ALDH2*1/2 heterozygotes was dominant over the ALDH2*1/1 subjects, a finding similar to that of the ALDH2 dehydrogenase activity (12,14). Although the GTN biotransformation catalytic activity was decreased for the heterozygous and homozygous mutants, a relatively higher activity remained, as compared with their respective dehydrogenase activities.…”
Section: Resultssupporting
confidence: 56%
See 1 more Smart Citation
“…In all forms of the enzymes assayed, the ratio of 1,2-GDN/1,3-GDN was constant at 8:1. Furthermore, the decreased GTN biotransformation in ALDH2*1/2 heterozygotes was dominant over the ALDH2*1/1 subjects, a finding similar to that of the ALDH2 dehydrogenase activity (12,14). Although the GTN biotransformation catalytic activity was decreased for the heterozygous and homozygous mutants, a relatively higher activity remained, as compared with their respective dehydrogenase activities.…”
Section: Resultssupporting
confidence: 56%
“…ALDH2 is a tetramer, and 1 defective subunit is sufficient to render the entire enzyme inactive; thus, Glu504 homozygotes (ALDH2*1/1) exhibit normal enzymatic activity, Glu504/Lys504 heterozygotes (ALDH2*1/2) show approximately 6% of normal activity, and Lys504 homozygotes (ALDH2*2/2) show negligible activity toward acetaldehyde (12). The ALDH2*2 allele is thus inherited as an autosomal dominant trait (11,12,14). This mutation has been considered as a protective factor against the development of alcoholism and may explain distinct alcohol drinking habits across various ethnic populations (13).…”
Section: Introductionmentioning
confidence: 99%
“…= 22, c 2 = 268.343). The three-group (0, 1-7, [8][9][10][11][12][13][14][15][16][17][18][19][20][21][22] or the two-group (0-7, 8-22) score distribution also showed significant proportional differences between AUD Past histories of diabetes mellitus (DM), chronic liver diseases (liver cirrhosis, chronic hepatitis, hepatic dysfunction and alcoholic liver dysfunction), AUD and blood transfusion were more prevalent among AUD patients (Table 1).…”
Section: Resultsmentioning
confidence: 99%
“…The variant subunit, encoded by ALDH2*2 , decreases the activity in the tetrameric enzyme. 10 The present matched case-control study was performed to investigate the relationship between the aforementioned potential risk factors, including ADH2 and ALDH2 genotypes, and AUD as diagnosed by psychiatrists in Japan.…”
Section: Introductionmentioning
confidence: 99%
“…The binding ability of these proteins depends on the cooperation of two or more motifs belonging to different subunits. Although a dominant negative mutation is not usually expected for diseases involving defects of enzymes, since enzymes are so active that there is no loss of function unless their levels have decreased to less than 10-15% of normal levels, several dominantly inherited metabolic diseases have been reported (Xiao et al 1995, Chamberlin et al 1997. In a heterozygous state, these mutants antagonize the activity of the remaining wild-type allele and give a phenotype approaching a null.…”
Section: Discussionmentioning
confidence: 99%